Related Experiment Video

Updated: Jul 9, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

CD200-CD200R regulation of microglia activation in the pathogenesis of Parkinson's disease

Xi-Jin Wang1, Min Ye, Yu-Hong Zhang

  • 1Department of Neurology & Institute of Neurology, Rui-Jin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, People's Republic of China.

Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|November 28, 2007
PubMed

Insights

The CD200-CD200R pathway influences microglia activation, a key factor in Parkinson's disease (PD) pathogenesis. Targeting this signaling pathway offers a promising therapeutic strategy for regulating microglia in PD.

Area of Science:

  • Neuroimmunology
  • Central Nervous System (CNS) Immune Regulation

Background:

  • The CD200-CD200R immune checkpoint pathway plays a critical role in regulating immune responses within the CNS.
  • Microglia, the resident immune cells of the brain, are increasingly implicated in the pathogenesis of neurodegenerative diseases like Parkinson's disease (PD).
  • A significant correlation has been observed between CD200-CD200R signaling, microglia activation, and the development and progression of PD.

Purpose of the Study:

  • To review the current understanding of the CD200-CD200R signaling pathway in the context of CNS immune regulation.
  • To elucidate the relationship between CD200-CD200R signaling, microglia activation, and Parkinson's disease.
  • To explore the potential of targeting CD200-CD200R signaling as a therapeutic strategy for PD.

Main Methods:

  • Literature review focusing on gene mapping, molecular structure, and expression patterns of CD200 and CD200R in the nervous system.
  • Analysis of studies investigating the impact of CD200-CD200R signaling on microglia activation.
  • Examination of research on the role of microglia activation in PD pathogenesis and progression.

Main Results:

  • CD200 and CD200R possess specific gene mappings and molecular structures relevant to their function.
  • Distinct distribution and expression profiles of CD200 and CD200R exist within the nervous system.
  • CD200-CD200R signaling directly influences microglia activation states.
  • Activated microglia play a crucial role in the pathological processes underlying PD.

Conclusions:

  • The CD200-CD200R pathway is a key regulator of microglia activation in the CNS.
  • Dysregulation of microglia activation is central to Parkinson's disease.
  • Targeting the CD200-CD200R signaling pathway presents a promising therapeutic avenue for modulating microglia activation and potentially treating PD.

More Related Videos

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility07:54

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Published on: April 13, 2017

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...